Edwards Lifesciences revives Fintiv challenge

14-03-2023

Muireann Bolger

Edwards Lifesciences revives Fintiv challenge

IgorGolovniov / Shutterstock.com

Medtech company wins reversal of earlier ruling | Door opens to mount a challenge of controversial rule | USPTO director‘s updated guidelines influence court’s reasoning.


Fintiv, USPTO, Edwards, parallel, proceeding, controversial, Lifesciences, Medtech, reversal, boards, inter, partes, institute, Circuit, directors, review

More on this story

Mylan, Edwards back NHK-Fintiv challenge
31-08-2021

LSIPR